- +18
James M. Acton, Saskia Brechenmacher, Cecily Brewer, …
{
"authors": [
"Tong Zhao"
],
"type": "legacyinthemedia",
"centerAffiliationAll": "dc",
"centers": [
"Carnegie Endowment for International Peace",
"Carnegie China"
],
"collections": [],
"englishNewsletterAll": "ctw",
"nonEnglishNewsletterAll": "",
"primaryCenter": "Carnegie China",
"programAffiliation": "NPP",
"programs": [
"Nuclear Policy"
],
"projects": [],
"regions": [
"North America",
"United States",
"East Asia",
"China"
],
"topics": [
"Security",
"Nuclear Policy",
"Foreign Policy"
]
}REQUIRED IMAGE
About the P5 process, RevCon 2022, AUKUS and US-China Competition From The Chinese Side
There are certainly other issues among other P5 countries, but the U.S.-China competition is so by far the most consequential great power rivalry in the international system, and it has very far-reaching geopolitical implications at and beyond the Pacific region.
About the Author
Senior Fellow with the Nuclear Policy Program and Carnegie China
Tong Zhao is a senior fellow with the Nuclear Policy Program and Carnegie China, Carnegie’s East Asia-based research center on contemporary China. Formerly based in Beijing, he now conducts research in Washington on strategic security issues.
- Unpacking Trump’s National Security StrategyOther
- The U.S. Venezuela Operation Will Harden China’s Security CalculationCommentary
Tong Zhao
Recent Work
Carnegie does not take institutional positions on public policy issues; the views represented herein are those of the author(s) and do not necessarily reflect the views of Carnegie, its staff, or its trustees.
More Work from Carnegie China
- Who Paid for China’s Last Debt Cleanup, and Who Will Pay for the Next?Commentary
China’s banking crisis in the 2000s was resolved by transferring the costs to households through financial repression—a decision that recapitalized the banks while exacerbating the structural imbalances that continue to shape the Chinese economy today.
Michael Pettis
- Caught in the Middle: Chinese Biotech Firms’ Divergent Responses to U.S. SanctionsCommentary
Chinese biotech companies have been on the receiving end of U.S. economic coercion. Yet their responses have differed significantly because firm and state interests are not uniformly aligned. For Washington, treating all Chinese tech firms the same, irrespective of their actual interests, risks pushing them farther into Beijing’s corner.
Xue Gong
- Are Data Centers the Solution to China’s Renewables Excess Capacity?Commentary
China’s latest energy plan explicitly calls for integrating data centers into the electricity system, particularly connecting them to green energy. It appears Beijing wants to use compute as a source of domestic demand to absorb renewables excess capacity.
Damien Ma
- Trump and Xi Are Angling for Three Years of StabilityCommentary
But their "principal to principal" model will only be as effective as the political strength of each leader back home.
Damien Ma
- China Sells Stability Amid American VolatilityCommentary
U.S. unpredictability has allowed China to capitalize on its positioning as the “responsible great power”. Paradoxically, the more China wins the perception game, the more likely expectations will rise for Beijing to deliver not just words but to demonstrate with its deeds.
Chong Ja Ian